Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Viagra poses dilemma for Europe's tradition of state-funded care

Article Abstract:

Pfizer Inc., a manufacturer of pharmaceutical preparations, expects to generate lower-than-expected sales for its new anti-impotency drug, Viagra, in the European region. The anticipated weak demand for the anti-impotency medication was spurred by the state-controlled structure of the healthcare system in the continent. Government-funded healthcare systems will place the burden of procurement to the citizenry, which is not a viable alternative due to the drug's high cost. Viagra was introduced into the US market in April 1998, and is expected to be distributed throughout Europe by autumn of 1998.

Comment:

Is expected to generate lower-than-expected sales for its new anti-impotency drug, Viagra, in the European region

Author: Moore, Stephen D., McKay, Betsy
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
Europe, Sales & consumption, Fertility Preparations, Pfizer Inc., Fertility agents, Article

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Glaxo unveils manufacturing overhaul

Article Abstract:

Glaxo Wellcome PLC introduced a strategy to overhaul its manufacturing operations worldwide. The strategy is designed to lower the company's yearly operating costs by 7% and to reduce its global payroll by as much as 5.7% over the next four year period. Glaxo said that the overhaul would create 370 million pound sterling (570.5 million euros) in yearly savings. In 2003, Glaxo will begin the first of 3,400 layoffs.

Author: Moore, Stephen D.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
United Kingdom, Financial management, Pharmaceutical Preparations, Management, Pharmaceutical industry, Drugs, Abstract, Glaxo Wellcome PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Rhone-Poulenc may team up with Hoechst. British Biotech signals a shift in its strategies. Bayer reconsiders independent stance
  • Abstracts: German Biotech sector is attracting U.S. firms. Hoechst in pact on its paints unit. Bayer posts healthy rise in second-quarter profit
  • Abstracts: Citibank leads partners in loan facility for Sumitomo. Itochu strives to restructure. Prudential to form venture
  • Abstracts: Critics blast status quo at Taiwan's state-owned banks. Orderly succession expected at Tsai group. Taiwan braces for more rifts between businesses, workers
  • Abstracts: Swiss Mobiliar decides to join Eureko Alliance. Insurer Swiss Life Agrees to Aquire Lloyd Continental
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.